Section 1e: Version 3 (V3)
Section 2: Clinical and Administrative Domains
HL7 Version 3 Standard: Common Product Model (CPM) CMETs, Release 4
DESCRIPTION
The common product model is used to improve the alignment between the different representations of products used within the body of HL7 Version 3 models. One goal of this effort is to make it possible for there to be a single such representation, which could then be used as a common message element type (CMET) across those models.
Within the context of this model, a "product" is defined in a broad fashion as "any material item or substance that can be offered to a market that might satisfy a want or need. However, items produced and consumed at home are also included.
ALTERNATIVE NAMES
HL7 Version 3 Standard: Common Product Model (CPM) CMETs, Release 4 may also go by the following names or acronyms:
TARGETS
- Regulatory Agencies
- Standards Development Organizations (SDOs)
- Pharmaceutical Vendors
- Equipment Vendors
BENEFITS
- Creates a common, consistent definition of product classes used in a variety of V3 based models, e.g., SPL (Structured Product Label), ICSR, Immunization and Pharmacy
IMPLEMENTATIONS/CASE STUDIES
- FDA
- EMA
- NLM
DEVELOPMENT BACKGROUND
The model content includes the structures and attributes needed to support product information for medical devices (including imaging devices).
RELATED DOCUMENTS
| HL7 Version 3 Standard: Common Product Model (CPM) CMETs, Release 4 |
|
TOPICS
- Pharmacy
- Regulated Products
- SPL
BALLOT TYPE
- Normative
STATUS DATE
2018-02-27RESPONSIBLE WORK GROUP
STAKEHOLDERS
- Equipment Vendors
- Pharmaceutical Vendors
- Standards Development Organizations (SDOs)
FAMILY
- V3
CURRENT STATE
- Retired
REALM
- Universal
